Establishing Ongoing Patient Involvement in Adult Autism Psychiatry and Neurodevelopmental Research: Insights from Sweden’s First Year

October 2, 2026 2 Min Read

Introduction to Patient and Public Involvement in Autism Research

Patient and public involvement (PPI) is gaining prominence in health research, including studies focused on autism. However, PPI efforts often occur on a project-by-project basis, limiting their continuity and broader impact. A recent study from western Sweden sheds light on the practical aspects of building recurring PPI structures that bridge clinical services and academic research in adult autism psychiatry and neurodevelopmental disorders.

Two Distinct PPI Models Established

The study describes the development and first-year experiences of two ongoing PPI frameworks:

Patient Panel: Linked to an adult autism psychiatry service, this panel involved autistic adults receiving psychiatric care. It was initially integrated within an existing research program.
Neurodevelopmental Disorders (NDD) Advisory Board: Based at the University of Gothenburg, this board was designed as a broader forum including researchers and representatives from patient and user organizations.

Activities and Contributions During the First Year

Throughout their inaugural year, both groups engaged in a variety of activities, such as:

Reviewing research materials and protocols
Reflecting on ethical and methodological issues
Contributing to intervention development
Discussing research findings and clinical service improvements
Providing input on wider neurodevelopmental research questions

These contributions led to tangible modifications in research processes and intervention content. Nevertheless, the involvement remained largely advisory, with ultimate decisions resting with researchers, project leaders, or clinical managers.

Challenges and Organizational Insights

Implementing these PPI structures highlighted several key factors:

Institutional Context: The Patient Panel, embedded within clinical care, required iterative development of procedures regarding recruitment, data protection, compensation, and organizational roles.
Administrative Ease: The university-based Advisory Board was simpler to establish administratively.
Governance and Decision-Making: Both structures showed underdeveloped governance frameworks, limited systematic documentation, and lacked shared decision-making mechanisms.
Accessibility and Support: Preparation, accessibility accommodations, compensation for contributors, and follow-up mechanisms were essential for effective involvement.

Alignment with Participatory Principles and Remaining Gaps

When evaluated against the AASPIRE principles for participatory research, the PPI initiatives demonstrated several positive practices. However, gaps remained, particularly in governance structures, accessibility protocols, and comprehensive involvement across all stages of research.

Implications for Sustained Patient Involvement

The Swedish experience illustrates that recurring PPI activities can be successfully established in both clinical and academic environments. However, setting up these structures does not guarantee their long-term sustainability or full institutional integration. Ongoing attention to organizational procedures, allocation of resources, accountability measures, accessibility, and equitable distribution of decision-making authority is necessary to maintain and deepen patient and public involvement.

Conclusion

This study provides valuable lessons for researchers and clinicians aiming to develop enduring PPI frameworks in autism and neurodevelopmental research. By addressing the highlighted challenges and fostering shared governance, such efforts can enhance the relevance and quality of research and clinical services.

For more detailed information, see the original publication: Building recurring public and patient involvement in adult autism psychiatry and neurodevelopmental research: lessons from the first year of a patient panel and advisory board.